<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-biomedicines-08-00060">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Martikainen</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ruotsalainen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Tuomela</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Härkönen</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Essand</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Heikkilä</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hinkkanen</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotypic human prostate tumours in mice</article-title>
  <source>Br. J. Cancer</source>
  <year>2017</year>
  <volume>117</volume>
  <fpage>51</fpage>
  <lpage>55</lpage>
  <pub-id pub-id-type="doi">10.1038/bjc.2017.151</pub-id>
  <?supplied-pmid 28557974?>
  <pub-id pub-id-type="pmid">28557974</pub-id>
 </element-citation>
</ref>
